VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MRM
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MRMMEDIROM Healthcare Technologies Inc.
$1.00$5M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksMRMQuarterly Financials

MEDIROM Healthcare Technologies Inc. (MRM) Quarterly Financials

120+ quarters historyFree accessUpdated daily

MEDIROM Healthcare Technologies Inc. (MRM) quarterly income statement — complete revenue, gross profit & net income history

MRM Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ2'25Q4'24Q2'24Q4'23Q2'23Q4'22Q2'22Q4'21Q2'21Q4'20Q2'20Q4'19Q4'18
Sales/Revenue3.15B4.82B3.48B3.59B3.24B3.81B1.57B1.64B2.13B992.67M678.14M938.37M1.02B
Revenue Growth %-9.3%34.55%7.17%-5.83%106.08%131.97%-26.04%65.33%213.72%5.79%--7.62%-
Cost of Goods Sold2.81B3.15B2.9B2.7B2.56B2.72B1.17B1.11B884.45M821.72M634.61M1.42B1.24B
COGS % of Revenue89.17%65.39%83.41%75.18%79.06%71.46%74.08%67.8%41.57%82.78%93.58%151.72%121.89%
Gross Profit341.53M1.67B576.56M889.91M678.96M1.09B407.9M528.42M179.29M170.95M43.53M453.05M478.43M
Gross Margin %10.83%34.61%16.59%24.82%20.94%28.54%25.92%32.2%8.43%17.22%6.42%48.28%47.1%
Gross Profit Growth %-40.77%87.63%-15.08%-18.11%66.45%105.64%127.51%209.11%311.88%-62.27%--5.31%-
Operating Expenses1.16B1.05B1.21B971.23M989.22M834.81M484.65M522.62M409.47M326.84M260.68M479.57M217.66M
OpEx % of Revenue36.68%21.79%34.91%27.09%30.51%21.93%30.8%31.84%19.25%32.92%38.44%51.11%21.43%
Selling, General & Admin1.16B1.03B1.21B971.23M989.22M835.99M484.75M485.01M1.33B273.59M794.95M460.14M421.41M
SG&A % of Revenue36.68%21.32%34.91%27.09%30.51%21.96%30.81%29.55%62.32%27.56%117.23%49.04%41.49%
Research & Development0000000000000
R&D % of Revenue-------------
Other Operating Expenses01000K000-1000K01000K-1000K1000K-1000K1000K-1000K
Operating Income-814.63M618.57M-636.67M-81.32M-310.26M251.85M-76.85M-229.49M-513.99M-528.93M-431.43M-14.02M57.02M
Operating Margin %-25.84%12.82%-18.32%-2.27%-9.57%6.62%-4.88%-13.98%-24.16%-53.28%-63.62%-1.49%5.61%
Operating Income Growth %-27.95%860.7%-105.2%-132.29%-303.7%209.74%85.05%56.61%-19.14%-3672.58%--124.59%-
EBITDA-569.82M712.51M-440.57M70.43M-209.41M345.49M-31.64M-186.19M-494.18M-514.34M-414.87M9.36M68.42M
EBITDA Margin %-18.08%14.77%-12.68%1.96%-6.46%9.07%-2.01%-11.34%-23.23%-51.81%-61.18%1%6.74%
EBITDA Growth %-29.34%911.65%-110.38%-79.61%-561.76%285.56%93.6%63.8%-19.12%-5594.81%--86.32%-
D&A (Non-Cash Add-back)244.81M93.94M196.1M151.75M100.85M93.64M45.21M43.31M19.82M14.59M16.55M23.38M11.4M
EBIT-814.63M734.13M-636.67M-81.32M-310.26M250.68M-76.85M43.41M-241.09M-102.64M-217.15M-3.55M53.7M
Net Interest Income-25.23M-29.11M-20.63M-18.08M16.86M1.62M2.67M2.47M3.09M3.25M2.7M-2.83M-3.3M
Interest Income49.57K8K131.06M16.86M1.62M2.67M2.47M3.09M3.25M2.7M-5.26M0
Interest Expense25.28M29.12M20.63M19.14M000000007.74M
Other Income/Expense143.22M13.91M51.9M453.27M-41.07M86.78M-2.57M48.29M73.48M114.22M10.3M-2.07M-11.42M
Pretax Income-671.41M632.48M-584.77M371.95M-351.33M338.63M-79.43M-181.21M-440.52M-414.72M-421.13M-16.09M45.6M
Pretax Margin %-21.3%13.11%-16.83%10.37%-10.83%8.89%-5.05%-11.04%-20.71%-41.78%-62.1%-1.71%4.49%
Income Tax126.34K-94.08M3.6M-98.16M3.73M8.12M11.34M260.52M27.61M-97.03M9.52M4.53M5.71M
Effective Tax Rate %-0.02%-14.88%-0.62%-26.39%-1.06%2.4%-14.28%-143.77%-6.27%23.4%-2.26%-28.17%12.53%
Net Income-671.06M730.94M-582.18M470.47M-355.07M330.51M-90.77M-234.48M-260.88M-48.1M-221.49M-36.71M33.16M
Net Margin %-21.29%15.15%-16.75%13.12%-10.95%8.68%-5.77%-14.29%-12.26%-4.85%-32.66%-3.91%3.26%
Net Income Growth %-15.27%55.36%-63.96%42.35%-291.17%240.95%65.21%-387.49%-17.79%-31.03%--210.72%-
Net Income (Continuing)-671.54M726.57M-588.38M470.12M-355.07M330.51M-90.77M-234.48M-260.88M-317.68M-221.49M-36.71M27.02M
Discontinued Operations0000000000000
Minority Interest55.14M254.79M-1.11M5.08M000000000
EPS (Diluted)-85.10118.73-118.5643.16-72.7254.54-18.59-48.03-53.55-11.95-55.06-8.807.04
EPS Growth %28.22%175.09%-63.04%-20.87%-291.18%213.55%65.28%-301.92%2.74%-35.8%--225%-
EPS (Basic)-85.10147.69-118.5686.32-72.7254.54-18.59-48.02-53.55-11.94-55.06-4.807.36
Diluted Shares Outstanding7.9M5.85M4.91M5.45M4.88M6.06M4.88M4.88M4.87M4.03M4.02M4.27M4.72M
Basic Shares Outstanding7.9M5.11M4.91M5.45M4.88M6.06M4.88M4.88M4.87M4.03M4.02M4.27M4.72M
Dividend Payout Ratio-------------